What Does The Temporary Pause In Production Of Excedrin Extra Strength And Excedrin Migraine Mean For Those Living With Migraine
Those living with migraine may have to find an alternative over the counter treatment to Excedrin Migraine as it is discontinued until further notice.
Both caplet and gel-tablets of Excedrin Extra Strength and Excedrin Migraine will be temporarily unavailable as GlaxoSmithKline works to resolve an inconsistency in how the ingredients are weighed. The company said in a statement that the production halt is a “precautionary measure” and that there are no safety risks associated with either product. However, both will be temporarily off the shelves until the issue is resolved.
For people using Excedrin to relieve recurring migraine attacks, this news may be concerning. But what sounds scary, could actually be the ticket to reducing the frequency of your migraine attacks.
Why? Because taking over-the-counter or prescription medications too frequently can actually cause Medication Overuse Headache. Overstimulating the brain pathways involved in reducing pain can create a dependence on medication. Not only does overuse make the medication less effective over time, it also causes pain between attacks and may trigger more frequent attacks. Overuse may even have a hand in progressing the disease from episodic to chronic.
If you rely on these Excedrin products for relief from migraine, the American Migraine Foundation recommends you schedule an appointment with your headache specialist to determine an alternate course of treatment.
Gsk Consumer Health Recalls Five Excedrin Brands Due To Failure To Meet Child Resistant Packaging Requirement; Risk Of Poisoning
Important: CPSC Recall Remedy Notice Due to COVID-19
Due to the extraordinary circumstances surrounding COVID-19, some of the remedies identified in recall press releases may not be available at this time. Consumers should check with recalling firms for further details.
It is important to remember that CPSC and recalling firms urge consumers not to use recalled products.
Recalled Excedrin with hole in the bottom of the bottle
Recalled Excedrin Migraine Caplets
Recalled Excedrin Migraine Geltabs
Recalled Excedrin Extra Strength Caplets
Recalled Excedrin PM Headache Caplets
Recalled Excedrin Tension Headache Caplets
Recalled Excedrin with hole in the bottom of the bottle
Recalled Excedrin Migraine Caplets
Recalled Excedrin Migraine Geltabs
Recalled Excedrin Extra Strength Caplets
Recalled Excedrin PM Headache Caplets
Recalled Excedrin Tension Headache Caplets
Some of the bottles containing the over-the-counter drug can have a hole in the bottom. If there is a hole, children could access and swallow the contents, posing a risk of poisoning. These products contain the substances aspirin and acetaminophen which must be in child resistant packaging as required by the Poison Prevention Packaging Act .
GSK Consumer Relations at 800-468-7746 from 8 a.m. to 6 p.m. ET Monday through Friday, or online at www.excedrin.com and click on the “safety issue” banner at the top of the page for more information.
One Less Item On The Market Means Fewer Choices For Americans Who Rely On The Medicine To Power
GlaxoSmithKline announced earlier this week that it has temporarily halted production of Excedrin Migraine and Excedrin Extra Strength, two of its most popular drugs to treat migraines and headaches.
Citing a precautionary measure with “inconsistencies in how we transfer and weigh ingredients,” the pharmaceutical giant explained that while it was a nation-wide issue, the drug should be available again in the future.
While GlaxoSmithKline does not believe there is a risk to the general public, one less item on the market means fewer choices for Americans who rely on the medicine to power-through often painful and debilitating migraines.
Understanding the impact of migraines
According to the Migraine Research Foundation, as the third most prevalent illness in the world, migraines affect 1 in 4 U.S. households. Most common between the ages of 18 and 44, migraine sufferers affect 18% of American women, 6% of men and 10% of children. Many sufferers cite a diminished quality of life, and anxiety as to when their next migraine may occur.
A 2019 study quoted in Neurology Advisor found that patients who experienced migraines had a significantly reduced visual quality of life. Those in the study who had chronic migraines had visual quality scores that were comparable to patients with Multiple Sclerosis.
Barriers starting to break down
Can medical marijuana help?
Are you a candidate for cannabis?
Migraine Sufferers Alert: Two Popular Excedrin Products Temporarily Discontinued
GlaxoSmithKline takes precautionary steps to ensure safety as inconsistencies in manufacture are investigated.
Two over-the-counter medicines that many headache and migraine sufferers rely on, Excedrin Extra Strength and Excedrin Migraine, will be hard to find in the coming days.
According to a statement from GlaxoSmithKline , the company that makes the drugs, production and distribution have been temporarily halted because of “inconsistencies in how we transfer and weigh ingredients.”
These inconsistencies were uncovered during routine quality control and assurance measures, according to a statement the company made to CNN. The products include Excedrin Extra Strength Caplets and Geltabs and Excedrin Migraine Caplets and Geltabs.
Still, that’s little consolation to people who have come to rely on these products to relieve pain.
“Millions of migraine sufferers use Excedrin, which is a combination of commonly available acetaminophen, aspirin, and the stimulant caffeine, which so many people consume in their coffee every day and in chocolate,” says Nauman Tariq, MBBS, associate professor and director of Johns Hopkins Headache Center in Baltimore. “Halting its production, although temporarily, will increase the anxiety and frustration in people with migraines.”
Patient advocate Paula K. Dumas, founder, CEO, and managing editor of MigraineAgain.com, agrees.
Excedrin Recalled For Holes In Bottles That Present Poisoning Risk To Children
More than 433,000 bottles of Excedrin are being recalled because of holes in the bottom of some bottles that can pose a poisoning risk to children.
The Consumer Product Safety Commission announced last week that GSK Consumer Healthcare, a division of pharmaceutical giant GlaxoSmithKline, is recalling five brands of the popular headache medication because of the packaging defects.
The holes in the plastic bottles can allow the pills to slip through and harm children who swallow them. Excedrin contains aspirin and acetaminophen, which federal law requires be in child-resistant packaging.
GSK in October announced it had asked retailers to stop selling specific lots of Excedrin due to the possibility of holes in the bottles supplied by the bottle manufacturer.
GSK did not immediately respond to a request for comment.
The brands subject to the recall are Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets and Excedrin Tension Headache Caplets, in 50, 80, 100, 125, 200, 250 and 300-count bottles, according to the CPSC. About 433,600 bottles are affected.
What Migraine Sufferers Need To Know About Excedrin As Production Is Halted
Managing your migraines just got a little harder. GlaxoSmithKline is temporarily halting the production and distribution of two popular migraine-relieving products: Excedrin Extra Strength and Excedrin Migraine.
The move to temporarily pull both drugs stems from inconsistencies with the ingredients, which are acetaminophen, aspirin and caffeine.
In a statement provided to Yahoo Lifestyle, GlaxoSmithKline said: “Patient safety and product quality are our utmost priorities at GSK. Through routine quality control and assurance measures, we discovered inconsistencies in how we transfer and weigh ingredients for Excedrin Extra Strength Caplets and Geltabs and Excedrin Migraine Caplets and Geltabs. Based on the available data, GSK believes that the product does not pose a safety risk to consumers. However, as a precautionary measure, GSK Consumer Healthcare voluntarily implemented a temporary discontinuation of production and distribution.”
The statement continued: “This is a short term issue for which we expect production to begin again shortly. In the meantime, other Excedrin products are available along with other pain-relieving drugs, but dosages may differ. Consumers should consult their pharmacist for the most suitable alternative product.”
So what should migraine and headache sufferers do in the meantime?
Read more from Yahoo Lifestyle:
Temporarily Out Of Stock Discontinued Or Recalled Excedrin Products
Excedrin® has always been a leader in headache pain relief, and we continue to focus specifically on products for headaches and migraines. We are pleased to share that we have resumed the production of Excedrin® Extra Strength and Migraine products. We have started shipments to retailers, and you should start seeing these products back on many store shelves. We recommend using our product locator tool to find Excedrin® products near you.
See a full list of impacted products below.
Cant Find Your Excedrin Medicine At The Store Here Are Some Options
LOUISVILLE, Ky. – A popular over-the-counter medication used to relieve migraines is hard to find right now.
Production for certain Excedrin products has temporarily been stopped. This has left many people wondering how they should deal with their debilitating headaches.
Manufacturer GlaxoSmithKline has halted production of Excedrin Migraine and Excedrin Extra Strength in caplet and gel tab forms after discovering inconsistencies in how it transfers and weighs ingredients. The pharmaceutical company said it does not believe there is a safety risk to consumers, and stopping production is only a precautionary measure.
WAVE 3 News went to a Walgreen’s store in downtown Louisville and found there were no more Excedrin Extra Strength or Excedrin Migraine on the shelves.
Norton Neuroscience Institute neurologist Dr. Brian Plato said that using a particular medication too often can lead to an increase in headaches and migraines. Pluto said this could be a chance for patients to explore other forms of treatment.
“There has just been this explosion in the last two years of treatments available to patients with migraines,” Plato said.
The FDA recently approved two new drugs aimed at stopping migraines as they happen.
Plato said there are also migraine preventative options like monthly, self-administered injections. Knowing options is important.
In the U.S., there are about 40 million people who get migraines. It can happen to anyone, but it’s mostly women in their mid 30 to 40s.
Recall Causing Headaches Long After Being Pulled From The Market
We have looked at how a can put people in danger when it remains on the market. Companies have a responsibility to make sure their products are safe and provide proper warnings for use. When these fail, residents in Florida and across the country can get hurt or sick and the product may need to be recalled.
After a recall, however, people continue to be affected by the unavailability of a product. Even when companies try to get a safer product out soon, it can take so long that consumers are left with few options. Six months ago, the migraine headache medicine Excedrin was pulled from the market after reports of contamination in the manufacturing plant.
Users of Excedrin rely on the medicine to relieve the symptoms associated with migraines. Some took Excedrin as soon as they felt a severe headache coming on and were able to prevent it from turning into a full-blown migraine. With the continued unavailability of the product, though, many sufferers are trying new – and in some cases, dangerous – alternatives.
While it is crucial that people have access to safe and reliable drugs, people continue to suffer when these products are pulled from the market. This is why it is important for companies to comply with safety procedures and standards from the beginning. When this fails to happen, people can get hurt and a product should be recalled.
Two Excedrin Products Are Temporarily Discontinued Company Says
Pharmaceutical company GlaxoSmithKline says it has temporarily discontinued two types of Excedrin items as a precautionary measure.
The company has suspended production and distribution of its Excedrin Extra Strength and Excedrin Migraine products, it said.
“Through routine quality control and assurance measures, we discovered inconsistencies in how we transfer and weigh ingredients for Excedrin Extra Strength Caplets and Geltabs, and Excedrin Migraine Caplets and Geltabs,” it said in a statement to CNN.
The company does not believe that the product poses a safety risk to consumers but has voluntarily implemented the measure as a precaution, it said.
“We are working hard to resolve the issue as quickly as possible, but at this point in time cannot confirm a definite date as to when supply will resume,” it said. “Other Excedrin products are available along with other pain-relieving drugs, but dosages may differ. Consumers should consult their pharmacist for the most suitable alternative product.”
GlaxoSmithKline described it as a short term issue, saying it expects production to resume shortly.
CNN’s Joe Sutton contributed to this report
Collier Officials Hope To Fix Gaping Hole On Us 41 By Wednesday
Around 433,600 bottles of Excedrin products are being recalled because some of the bottles may have a hole in the bottom.
The plastic bottles pose a poisoning risk, if there’s a hole, because a child may be able to get the caplets and swallow the painkillers.
GSK Consumer Health issued the recall for five types of Excedrin products toward the end of December 2020.
Consumers should immediately check Excedrin bottles to see if there is a hole at the bottom. If there isn’t a hole, the consumers can keep the over-the-counter medicine, according to the recall.
The recall covers 50, 80, 100, 125, 200, 250 and 300-count bottles of Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets. The drugs were sold nationwide and online from March 2018 through September 2020.
The recall notice posted by the U.S. Consumer Product Safety Commission said because Excedrin contains aspirin and acetaminophen it must be in child resistant packaging as required by the Poison Prevention Packaging Act .
If there is a hole, consumers should contact GSK Consumer Relations for information on how to receive a prepaid shipping label for return to receive a full refund. You can contact GSK Consumer Relations at 800-468-7746 from 8 a.m. to 6 p.m. ET Monday through Friday, or online at Excedrin’s website and click on the “safety issue” banner at the top of the page for more information.
Excedrin Migraine Production Discontinued Until Further Notice
Many Americans reach for a bottle of Excedrin when they feel a Migraine attack coming on. It’s not perfect , but for some, it works. Pharmacy shelves are now empty of Excedrin Extra Strength and Excedrin Migraine – leaving thousands of people with Migraine scrambling for an alternative.
According to GlaxoSmithKline , the company behind Excedrin Migraine, production and distribution have been halted temporarily because of “inconsistencies in how we transfer and weigh ingredients.”
Both gel-caps and tablets of Excedrin Migraine and Excedrin Extra Strength will be off shelves until the company works out the issue. You can expect an Excedrin Migraine shortage for at least the next few months.
Should I Take The Excedrin Migraine I Currently Have At Home
We know youâ€™re hoping to hear that itâ€™s definitely safe to take the ExcedrinÂ® Migraine you already have, but weâ€™d never tell you anything we werenâ€™t 100% sure of. Even though this isnâ€™t a recall, we donâ€™t have enough information to answer this.
If you have any questions or concerns about your ExcedrinÂ®, you should contact a pharmacist for specific advice.
Migraine Sufferers Scramble For Relief After Excedrin Recall
Some turning to eBay after recall leaves stores without Excedrin Migraine.
Excedrin Plant Problems Spur Black Market
July 10, 2012? — It was about six months ago when Erin Terjesen opened up her medicine cabinet and realized, to her horror, that she was out of the medication she relied on to keep her headaches from turning into full-blown migraines.
A few minutes later, she stumbled into her pharmacy to search for the medication — Excedrin Migraine — but learned there was none in stock.
Her pharmacist told her that the manufacturer, Novartis, had announced a massive recall of its Excedrin, No-Doz, Bufferin and Gas-X products on Jan. 8.
Six months later, store shelves are still Excedrin-free. Novartis attributed the recall to problems at its Nebraska plant that could have led to contamination by other medications produced there.
In a statement, Novartis said it was “working very hard to return products to store shelves.” The company plans to restart production on a “line-by-line, product-by-product basis” to assure quality, and hopes to start restocking some products in the second half of the year.
There is no word yet on which of the recalled products will be manufactured first.
“The pharmacist recommended the store brand, but it made me super sick,” Terjesen said. “I wasn’t sure if I got sick because the migraine was so advanced and the nausea was part of it, but I took it a few other times after that and it just doesn’t work for me.”
Gunman Shot And Killed After Firing At Police Officials Say
We called some local pharmacies to ask if they had any Excedrin left and the handful we reached out to all said they had none.
Pharmacies like CVS, Walmart, and Walgreens have generic brands in their stock that have been substitutes for some of Excedrin’s products. Advil, Ibuprofen and Motrin have also served as alternatives for the migraine and headache pills.
The only way that you can get Excedrin is by finding the drug in single-dose packets though there are some for sale online if you look around.
Novartis has asked consumers to either destroy the identified products or return the unused bottles for refunds.
Novartis’ Consumer and Relationship Center has said that they expect Excedrin to be back in stores in June or July but no exact date has been offered.
Excedrin Migraine And Advil Migraine Come With Moh Warning
This sounds like bad news for people with Migraine who are now wondering what they’re going to take when they get an attack. However, it may be a blessing in disguise. Although they are affordable and easy to access, over-the-counter meds like Excedrin Migraine can too easily lead to increased pain if taken too often
Research suggests that, when taken more than once or twice a week, NSAIDs and triptans can alter the serotonin system within the brain, interfering with the body’s pain response and leading to increased pain sensitivity
The risk of MOH is especially high with drugs that contain more than one active ingredient . Combination analgesics like Excedrin Migraine and Excedrin Advil are required by the FDA to come with a warning printed on the drug fact label:
“Medication Overuse Headache Warning: Headaches may worsen if this product is used 10 or more days a month.”
Glaxosmithkline Halts Production Of Some Excedrin Products
GlaxoSmithKline does not know when it will resume producing Excedrin.
Excedrin temporarily stops production
Pharmaceutical giant GlaxoSmithKline has temporarily stopped production of Excedrin, its popular over-the-counter migraine medication.
The company ceased nationwide production and distribution of its Excedrin Extra Strength and Excedrin Migraine products because of “inconsistencies in how we transfer and weigh ingredients,” a GSK spokesperson told told ABC Syracuse affiliate WSYR.
GSK confirmed to ABC News it is a nationwide issue, although the company said it is short-term and production is expected to resume shortly. WSYR reported the company said there is not “a definite date as to when supply will resume.”
“Patient safety and product quality are our utmost priorities at GSK,” a company spokesperson said in a statement obtained by ABC News.
While the company does not believe Excedrin products pose a safety risk to consumers, the spokesperson said, GSK was temporarily discontinuing the medicines as a precautionary measure.
Other GSK pain medicines and generic drugs are still available, but they may be in different dosage, and GSK advises consumers to consult their pharmacists for alternatives, the spokesperson said in their statement.
Some patients say those options don’t provide them with the pain relief they need.
Excedrin Migraine Alternatives: What You Can Take Instead
We know having trouble getting the medication you need is really frustrating, especially when there are already so few effective over-the-counter options for migraine sufferers. Luckily, there are alternative treatments that you could try if youâ€™re affected by the ExcedrinÂ® Migraine shortage.
If you’re looking for an acute medication that’s more effective, you should talk to a doctor to see if a prescription treatment makes more sense for you. Naproxen, for example, is another NSAID that might work better for you than ExcedrinÂ® Migraine. In addition, there are seven different types of triptans, a medication thatâ€™s specifically designed to reduce the severity of migraine attacks. As always, a doctor is the best resource if you have any concerns.
We know itâ€™s not easy for migraine sufferers to just switch to another medication. Migraines are personal and we fully understand that it can take time to find the right one. If youâ€™d like to talk to a Cove doctor about potential migraine treatment options, you can get started here.
The information provided in this article is not a substitute for professional medical advice, diagnosis, or treatment. You should not rely upon the content provided in this article for specific medical advice. If you have any questions or concerns, please talk to your doctor.
Two Popular Excedrin Products Pulled From Shelves Amid
Two popular Excedrin products pulled from shelves amid fears poorly measured ingredients could leave consumers with unpredictable doses Excedrin Extra Strength and ExcedrinEstimated Reading Time: 4 minsTwo varieties of Excedrin pulled off market as precaution, GlaxoSmithKline, Name Brand ?Excedrin? And Other Drugs – Business …”>The company has temporarily stopped production of Excedrin Extra Strength and Excedrin Migraine products, and Excedrin Migraine Caplets and Geltabs.” The company urged customers to consult with a physician if they needed toEstimated Reading Time: 40 secsMidrin medication was taken off the shelves years ago, Excedrin Extra Strength and Excedrin Migraine, “Through routine quality control and assurance measures,
Excedrin Products Pulled Off Shelves As A Precaution
40 secs readThe maker of Excedrin reportedly is taking two versions of the pain medication off the market temporarily out of caution, If a hole isWhich Excedrin products have been recalled in 2020?As of November 2020, Excedrin ® pain relief products have been relieving the toughest headache pain for nearly 60 years, GlaxoSmithKline has suspended production andHaving done this they were allowed by the FDA to market a separate product specifically called Excedrin Migraine, Why is there a shortage of Excedrin®? In their official statement
What Is The Difference Between Tylenol And Excedrin
Both Excedrin® and TYLENOL® temporarily relieve minor aches and pains. TYLENOL®, which contains acetaminophen, can be a more appropriate option for those with stomach problems than Excedrin®, which contains a combination of the active ingredients, acetaminophen, aspirin and caffeine.
What Happens If You Overdose On Excedrin Migraine
Do not take more of Excedrin Migraine than is recommended. An overdose of acetaminophen can damage your liver or cause death. Call your doctor at once if you have nausea, pain in your upper stomach, itching, loss of appetite, dark urine, clay-colored stools, or jaundice .
When Can I Expect Excedrin To Be Fully In Stock
We are pleased to share that we have resumed the production of Excedrin® Extra Strength and Migraine products. We have started shipments to retailers, and you should start seeing these products back on many store shelves. We recommend using our product locator tool to find Excedrin® products near you.
Production Of Two Excedrin Painkillers Halted
Excedrin is one of those trusted brands that has been around for decades, I can’t understand how Rolaids could just go away like that GlaxoSmithKline is temporarily halting the production and distribution of two popular migraine-relieving products: Excedrin Extra Strength and
Having done this they were allowed by the FDA to market a separate product specifically called Excedrin Migraine, you may want to temporarily halt that, I called the Rolaids 1-800 number and I stayed on hold for 40 minutes and got tired of holding, While our large count bottles aren’t available right now, We were experiencing a temporary supply issue with Excedrin Extra Strength and Migraine products and workedHas Excedrin extra strength been recalled?We have asked retailers to stop selling larger size bottles of Excedrin Extra Strength, it said.The company has temporarily stopped production of Excedrin Extra Strength and Excedrin Migraine products, and now they have taken off Excedrin which is the only thing that gets rid of headaches for me, According to the current manufacturer , While GlaxoSmithKline doesn’t believe that there areGlaxoSmithKline is temporarily halting the production and distribution of two popular migraine-relieving products: Excedrin Extra Strength and